Skip to main content
Journal cover image

The clinical utility of FFRCT stratified by age.

Publication ,  Journal Article
Anastasius, M; Maggiore, P; Huang, A; Blanke, P; Patel, MR; Nørgaard, BL; Fairbairn, TA; Nieman, K; Akasaka, T; Berman, DS; Raff, GL; Amano, T ...
Published in: Journal of cardiovascular computed tomography
March 2021

CT coronary angiography (CTA) with Fractional Flow Reserve as determined by CT (FFRCT) is a safe alternative to invasive coronary angiography. A negative FFRCT has been shown to have low cardiac event rates compared to those with a positive FFRCT. However, the clinical utility of FFRCT according to age is not known.Patients' in the ADVANCE (Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care) registry, were stratified into those ≥65 or <65 years of age. The impact of FFRCT on clinical decision-making, as assessed by patient age, was determined by evaluating patient management using CTA results alone, followed by site investigators submitting a report on the treatment plan based upon the newly provided FFRCT data. Outcomes at 1-year post CTA were assessed, including major adverse cardiovascular events (myocardial infarction, all-cause mortality or unplanned hospitalization for ACS leading to revascularisation) and total revascularisation. Positive FFRCT was deemed to be ​≤ ​0.8.FFRCT was calculated in 1849 (40.6%) subjects aged <65 and 2704 (59.4%) ​≥ ​65 years of age. Subjects ≥65 years were more likely to have anatomic obstructive disease on CTA (≥50% stenosis), compared to those aged <65 (69.7% and 73.2% respectively, p ​= ​0.008). There was a similar graded increase in recommended and actual revascularisation with either CABG or PCI, with declining FFRCT strata for subjects above and below the age of 65. MACE and revascularisation rates were not significantly different for those ​≥ ​or <65, regardless of FFRCT positivity or stenosis severity <50% or ≥50%. With a negative FFRCT result, and anatomical stenosis ≥50%, those ​≥ ​and <65 years of age, had similar rates of MACE (0.2% for both, p ​= ​0.1) and revascularisation (8.7% and 10.4% respectively p ​= ​0.4). Logistic regression analysis, with age as a continuous variable, and adjustment for Diamond Forrester Risk, baseline FFRCT and treatment (CABG, PCI, medical therapy), indicated a statistically significant, but small increase in the odds of a MACE event with increasing age (OR 1.04, 95% CI 1.006-1.08, p ​= ​0.02). Amongst patients with a FFRCT > 0.80, there was no effect of age on the odds of revascularisation.The findings of this study point to a low risk of MACE events or need for revascularisation in those aged ​≥ ​or <65 with a FFRCT>0.80, despite the higher incidence of anatomic obstructive CAD in those ≥65 years. The findings show the clinical usefulness and outcomes of FFRCT are largely constant regardless of age.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Journal of cardiovascular computed tomography

DOI

EISSN

1876-861X

ISSN

1934-5925

Publication Date

March 2021

Volume

15

Issue

2

Start / End Page

121 / 128

Related Subject Headings

  • Risk Factors
  • Risk Assessment
  • Registries
  • Radiographic Image Interpretation, Computer-Assisted
  • Prospective Studies
  • Prognosis
  • Predictive Value of Tests
  • Middle Aged
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Anastasius, M., Maggiore, P., Huang, A., Blanke, P., Patel, M. R., Nørgaard, B. L., … Leipsic, J. (2021). The clinical utility of FFRCT stratified by age. Journal of Cardiovascular Computed Tomography, 15(2), 121–128. https://doi.org/10.1016/j.jcct.2020.08.006
Anastasius, Malcom, Paul Maggiore, Alex Huang, Phillip Blanke, Manesh R. Patel, Bjarne Linde Nørgaard, Timothy A. Fairbairn, et al. “The clinical utility of FFRCT stratified by age.Journal of Cardiovascular Computed Tomography 15, no. 2 (March 2021): 121–28. https://doi.org/10.1016/j.jcct.2020.08.006.
Anastasius M, Maggiore P, Huang A, Blanke P, Patel MR, Nørgaard BL, et al. The clinical utility of FFRCT stratified by age. Journal of cardiovascular computed tomography. 2021 Mar;15(2):121–8.
Anastasius, Malcom, et al. “The clinical utility of FFRCT stratified by age.Journal of Cardiovascular Computed Tomography, vol. 15, no. 2, Mar. 2021, pp. 121–28. Epmc, doi:10.1016/j.jcct.2020.08.006.
Anastasius M, Maggiore P, Huang A, Blanke P, Patel MR, Nørgaard BL, Fairbairn TA, Nieman K, Akasaka T, Berman DS, Raff GL, Hurwitz Koweek LM, Pontone G, Kawasaki T, Rønnow Sand NP, Jensen JM, Amano T, Poon M, Øvrehus KA, Sonck J, Rabbat MG, Mullen S, De Bruyne B, Rogers C, Matsuo H, Bax JJ, Leipsic J. The clinical utility of FFRCT stratified by age. Journal of cardiovascular computed tomography. 2021 Mar;15(2):121–128.
Journal cover image

Published In

Journal of cardiovascular computed tomography

DOI

EISSN

1876-861X

ISSN

1934-5925

Publication Date

March 2021

Volume

15

Issue

2

Start / End Page

121 / 128

Related Subject Headings

  • Risk Factors
  • Risk Assessment
  • Registries
  • Radiographic Image Interpretation, Computer-Assisted
  • Prospective Studies
  • Prognosis
  • Predictive Value of Tests
  • Middle Aged
  • Male
  • Humans